10:27 EDT Summit Therapeutics (SMMT) up 1% after report on AstraZeneca (AZN) partnership talks
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT:
- AstraZeneca discussing $15B partnership with Summit Therapeutics, Bloomberg says
- Summit Therapeutics trading resumes
- Summit Therapeutics in talks for $15B AstraZeneca partnership, Bloomberg says
- Summit Therapeutics trading halted, volatility trading pause
- Strategic Collaboration and Growth Potential Drive Positive Outlook for Summit Therapeutics